Cargando…

Comparative study of clinical grade human tolerogenic dendritic cells

BACKGROUND: The use of tolerogenic DCs is a promising therapeutic strategy for transplantation and autoimmune disorders. Immunomodulatory DCs are primarily generated from monocytes (MDDCs) for in vitro experiments following protocols that fail to fulfil the strict regulatory rules of clinically appl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naranjo-Gómez, M, Raïch-Regué, D, Oñate, C, Grau-López, L, Ramo-Tello, C, Pujol-Borrell, R, Martínez-Cáceres, E, Borràs, Francesc E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141500/ https://www.ncbi.nlm.nih.gov/pubmed/21658226 http://dx.doi.org/10.1186/1479-5876-9-89

Ejemplares similares

Tolerogenic dendritic cells in experimental autoimmune encephalomyelitis, specific tolerance induction?
por: Sellés-Moreno, Carla, et al.
Publicado: (2012)

Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients
por: Grau-López, Laia, et al.
Publicado: (2012)

Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin
por: Navarro-Barriuso, Juan, et al.
Publicado: (2018)

Cryopreserved vitamin D(3)-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
por: Mansilla, María José, et al.
Publicado: (2016)

Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4(+) Cells Towards a Functional Hyporesponsiveness
por: Navarro-Barriuso, Juan, et al.
Publicado: (2021)

Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2021)

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients
por: Navarro-Barriuso, Juan, et al.
Publicado: (2019)

Ethyl Pyruvate Induces Tolerogenic Dendritic Cells
por: Djedovic, Neda, et al.
Publicado: (2019)

Characterization of recent thymic emigrants (RTEs), transitional B and Th17 cells in multiple sclerosis (MS)
por: Teniente-Serra, Aina, et al.
Publicado: (2011)

Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration
por: Mansilla, María José, et al.
Publicado: (2023)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017)

Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort
por: Ten Brinke, Anja, et al.
Publicado: (2015)

Searching for the Transcriptomic Signature of Immune Tolerance Induction—Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory Macrophages
por: Navarro-Barriuso, Juan, et al.
Publicado: (2018)

Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
por: Nikolic, Tatjana, et al.
Publicado: (2013)

Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2011)

Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2012)

Tolerogenic and Activatory Plasmacytoid Dendritic Cells in Autoimmunity
por: Guéry, Leslie, et al.
Publicado: (2013)

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications
por: Yoo, Seungbo, et al.
Publicado: (2016)

Metabolism Is Central to Tolerogenic Dendritic Cell Function
por: Sim, Wen Jing, et al.
Publicado: (2016)

Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity
por: Passeri, Laura, et al.
Publicado: (2021)

Functional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity
por: Nam, Ji-Hee, et al.
Publicado: (2021)

Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
por: Willekens, Barbara, et al.
Publicado: (2019)

Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator
por: Mansilla, María José, et al.
Publicado: (2021)

Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice
por: Pujol-Autonell, Irma, et al.
Publicado: (2013)

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
por: Harry, Rachel A, et al.
Publicado: (2010)

Cell therapy using tolerogenic dendritic cells in transplantation
por: Moreau, Aurélie, et al.
Publicado: (2012)

Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man
por: Raker, Verena K., et al.
Publicado: (2015)

Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update
por: Švajger, Urban, et al.
Publicado: (2018)

Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020)

Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells
por: Adamik, Juraj, et al.
Publicado: (2022)

Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells
por: Hubo, Mario, et al.
Publicado: (2013)

The nature of activatory and tolerogenic dendritic cell-derived signal II
por: Bakdash, Ghaith, et al.
Publicado: (2013)

The Nature of Activatory and Tolerogenic Dendritic Cell-Derived Signal 2
por: Granucci, Francesca, et al.
Publicado: (2014)

MicroRNA Profiling of Activated and Tolerogenic Human Dendritic Cells
por: Stumpfova, Zuzana, et al.
Publicado: (2014)

The Nature of Activatory and Tolerogenic Dendritic Cell-Derived Signal 2
por: Granucci, Francesca, et al.
Publicado: (2013)

Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
por: Xie, Zhong-Xiang, et al.
Publicado: (2015)

Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone
por: Lee, Jae-Hee, et al.
Publicado: (2017)

Lactoferrin Induces Tolerogenic Bone Marrow-Derived Dendritic Cells
por: Park, Hui-Won, et al.
Publicado: (2020)

Transcriptomic Analysis Identifies A Tolerogenic Dendritic Cell Signature
por: Robertson, Harry, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_990ev7b2ke61s3usij4isriing